Cite
Drug-Refractory Trigeminal Neuralgia: Treatment via Botulinum Toxin Type A
MLA
Behnam Bohluli, et al. Drug-Refractory Trigeminal Neuralgia: Treatment via Botulinum Toxin Type A. Aug. 2016. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....def63bb81e0bbd933921750c74b776c3&authtype=sso&custid=ns315887.
APA
Behnam Bohluli, MisaqHeydari, Mohammad Hosein Kalantar Motamedi, & Milad Heydari. (2016). Drug-Refractory Trigeminal Neuralgia: Treatment via Botulinum Toxin Type A.
Chicago
Behnam Bohluli, MisaqHeydari, Mohammad Hosein Kalantar Motamedi, and Milad Heydari. 2016. “Drug-Refractory Trigeminal Neuralgia: Treatment via Botulinum Toxin Type A,” August. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....def63bb81e0bbd933921750c74b776c3&authtype=sso&custid=ns315887.